{
  "nav": {
    "about": "About",
    "aboutCompany": "Company",
    "aboutTeam": "Scientific Team",
    "aboutCerts": "Certifications",
    "aboutPatents": "Patents",
    "aboutPartners": "Partners",
    "products": "Products & Solutions",
    "productsOverview": "Products",
    "solutions": "Solutions",
    "pipeline": "Pipeline",
    "news": "News",
    "newsCompany": "Company News",
    "newsIndustry": "Industry Insights",
    "newsArticles": "Publications",
    "contact": "Contact",
    "contactInfo": "Contact Info",
    "contactJobs": "Careers"
  },
  "hero": {
    "slogan": "Master Aging, Elevate Life",
    "subtitle": "Precision Anti-Aging Solutions Powered by Exosome Technology & AI Digital Twin",
    "cta1": "Learn More",
    "cta2": "Contact Us"
  },
  "business": {
    "title": "Three Core Pillars",
    "subtitle": "Building a full-chain anti-aging ecosystem centered on exosome technology",
    "ai": {
      "title": "AI Health Management",
      "desc": "Digital Twin Intelligent Anti-Aging Platform — personalized health management through multi-omics data modeling, precise biological age and aging rate assessment"
    },
    "exosome": {
      "title": "Functional Exosome Products",
      "desc": "Exosome Engineering Platform — developing standardized, scalable functional exosome products for skin rejuvenation, joint repair, neuroprotection and more"
    },
    "clinical": {
      "title": "Clinical Research Translation",
      "desc": "Partnering with top-tier hospitals for exosome clinical research, accelerating translation from bench to bedside"
    }
  },
  "whyNow": {
    "title": "Why Now?",
    "subtitle": "Three converging trends are driving the longevity tech boom",
    "tech": {
      "title": "Technology Inflection Point",
      "desc": "Exosome engineering matured, AI biological modeling breakthrough — precision anti-aging moves from concept to product"
    },
    "policy": {
      "title": "National Strategic Priority",
      "desc": "'Healthy China 2030' and 'Silver Economy' national strategies provide strong policy support for the anti-aging sector"
    },
    "consumer": {
      "title": "Generational Consumer Shift",
      "desc": "New high-net-worth individuals shifting from reactive to preventive healthcare, willing to pay premium for science-backed solutions"
    }
  },
  "painPoints": {
    "title": "Industry Pain Points & Our Solutions",
    "items": [
      {
        "pain": "Anti-aging products lack scientific validation, low consumer trust",
        "solution": "Joint clinical research with top hospitals, backed by evidence-based medical data"
      },
      {
        "pain": "Inconsistent exosome product quality, no unified standards",
        "solution": "Engineering platform enables standardized production with full traceability"
      },
      {
        "pain": "One-size-fits-all health management, lacking personalization",
        "solution": "AI digital twin modeling delivers precision plans based on multi-omics data"
      },
      {
        "pain": "Medical aesthetics clinics lack differentiated premium anti-aging programs",
        "solution": "End-to-end solution: Assessment → Plan → Product → Follow-up"
      }
    ]
  },
  "cta": {
    "title": "Pioneering the New Era of Scientific Anti-Aging",
    "subtitle": "Whether you are a medical aesthetics clinic, health management center, hospital, or brand — we look forward to exploring the commercialization of longevity technology together",
    "formName": "Name",
    "formCompany": "Company / Organization",
    "formPhone": "Phone",
    "formEmail": "Email",
    "formMessage": "Partnership Needs",
    "formSubmit": "Submit",
    "formSuccess": "Thank you for your submission. We will contact you shortly!"
  },
  "about": {
    "title": "About Us",
    "companyTitle": "Company Overview",
    "companyDesc": "Shanghai Xiaoling Biomedical Technology Co., Ltd. (X-AGEING) was founded in January 2025, headquartered in Zhangjiang Science City, Shanghai, with angel investment from OBiO Technology. The company focuses on R&D and application of exosome technology and AI digital twins in anti-aging, committed to becoming a global leader in precision anti-aging solutions.",
    "mission": "Core Philosophy",
    "missionDesc": "Centered on 'Exosome-Based Balanced Anti-Aging', leveraging the natural intercellular communication mechanism of exosomes to achieve precise regulation and multi-system balanced repair of the human aging process.",
    "market": "Market Direction",
    "marketDesc": "Deep focus on the intersection of anti-aging and regenerative medicine, serving medical aesthetics clinics, premium health check centers, top-tier hospitals, and consumer brands with end-to-end solutions from assessment to intervention.",
    "advantages": "Core Advantages",
    "advantageItems": [
      "Exosome Engineering Production Platform",
      "AI Digital Twin Biological Age Assessment System",
      "Top-Tier Hospital Joint Clinical Research Network",
      "Integrated Industry-Academia-Research Translation"
    ],
    "teamTitle": "Scientific Team",
    "teamDesc": "World-class scientists and industry experts, cross-disciplinary expertise in exosome engineering and AI biological modeling",
    "certsTitle": "Certifications",
    "certsDesc": "Comprehensive qualification system ensuring R&D and production compliance",
    "patentsTitle": "Patents",
    "patentsDesc": "Proprietary intellectual property building core technology moats",
    "partnersTitle": "Partners",
    "partnersDesc": "Deep collaborations with leading hospitals, research institutes, and industry capital",
    "partnerList": [
      "Zhongshan Hospital, Fudan University",
      "Suzhou Kowloon Hospital",
      "OBiO Technology (Shanghai) Co., Ltd.",
      "Shanghai Shenzer Venture Capital Management Co., Ltd.",
      "CASSTAR",
      "Danaher (China)",
      "Shanghai Jiao Tong University School of Medicine",
      "CAS Center for Excellence in Molecular Cell Science",
      "Shanghai Public Health Clinical Center",
      "National Center for Protein Sciences"
    ]
  },
  "products": {
    "title": "Products & Solutions",
    "subtitle": "Technology-driven, building full-scenario anti-aging solutions",
    "product1Title": "Digital Twin Intelligent Anti-Aging Platform",
    "product1Desc": "Building personal digital twin models through multi-omics data (genomics, proteomics, metabolomics), precisely assessing biological age, aging rate, and organ function status to tailor personalized anti-aging plans for each user.",
    "product2Title": "Exosome Engineering Platform",
    "product2Desc": "Proprietary exosome engineering platform enabling efficient isolation, purification, functional modification, and scaled production. Products include skin rejuvenation serums, joint repair preparations, and neuroprotective factors.",
    "solutionsTitle": "Solutions",
    "solution1": {
      "title": "Medical Aesthetics Solution",
      "desc": "Providing clinics with a closed-loop anti-aging service: Assessment → Custom Plan → Exosome Products → Outcome Tracking"
    },
    "solution2": {
      "title": "Health Check Center Solution",
      "desc": "AI biological age assessment + anti-aging intervention plans, upgrading health centers with 'Health Management + Precision Anti-Aging' services"
    },
    "solution3": {
      "title": "Hospital Clinical Research",
      "desc": "Multi-center clinical research in anti-aging and regenerative medicine with top-tier hospitals, driving translational outcomes"
    },
    "solution4": {
      "title": "Brand Co-Development",
      "desc": "Providing exosome raw materials and technical support for consumer brands to jointly develop premium anti-aging skincare/health product lines"
    },
    "pipelineTitle": "R&D Pipeline",
    "pipelineDesc": "Multiple parallel pipelines covering skin rejuvenation, joint repair, neurodegenerative diseases and more"
  },
  "news": {
    "title": "News & Insights",
    "company": "Company News",
    "industry": "Industry Insights",
    "articles": "Publications",
    "readMore": "Read More",
    "noArticles": "No articles yet — stay tuned"
  },
  "contact": {
    "title": "Contact Us",
    "infoTitle": "Contact Information",
    "company": "Shanghai Xiaoling Biomedical Technology Co., Ltd.",
    "companyEn": "XIAOLING X-AGEING",
    "contactPerson": "Zhou Shuo",
    "email": "zhoushuo@x-ageing.com",
    "address": "Zhangjiang Science City, Pudong New Area, Shanghai",
    "partnerTitle": "Business Partnership",
    "partnerDesc": "We welcome partnerships with medical aesthetics clinics, health management centers, hospitals, and consumer brands",
    "jobsTitle": "Careers",
    "jobsDesc": "We are looking for talented individuals passionate about longevity technology to pioneer the new era of anti-aging"
  },
  "footer": {
    "company": "Shanghai Xiaoling Biomedical Technology Co., Ltd.",
    "privacy": "Privacy Policy",
    "legal": "Legal Notice",
    "disclaimer": "Disclaimer",
    "icp": "沪ICP备XXXXXXXX号",
    "copyright": "© {year} X-AGEING. All rights reserved."
  }
}
